Relapsing-remitting multiple sclerosis and Cardiac failure

Summary:

Cardiac failure is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Cardiac failure with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 99 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Cardiac failure?

Cardiac failure is found to be associated with 2,055 drugs and 2,210 conditions by eHealthMe. Check the latest studies of Cardiac failure.

On Jul, 18, 2026

99 people who have Relapsing-Remitting Multiple Sclerosis and Cardiac Failure are studied.

Would you have Cardiac failure when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Cardiac Failure *:

female: 68.42 %
male: 31.58 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Cardiac Failure *:

Common co-existing conditions for these people *:

Urinary Tract Infection: 10 people, 10.10%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 10.10%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 9 people, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 9.09%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 8 people, 8.08%
Progressive Relapsing Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both): 4 people, 4.04%
Pain: 4 people, 4.04%
High Blood Pressure: 4 people, 4.04%
Depression: 4 people, 4.04%
Headache (pain in head): 3 people, 3.03%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 22 people, 22.22%
High Blood Pressure: 21 people, 21.21%
Pain: 18 people, 18.18%
Influenza Like Illness: 17 people, 17.17%
Weakness: 16 people, 16.16%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 16 people, 16.16%
Weight Increased: 15 people, 15.15%
Gait Disturbance: 15 people, 15.15%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 15 people, 15.15%
Fall: 15 people, 15.15%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cardiac failure?

- Check whether Cardiac failure is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Relapsing-remitting multiple sclerosis (76,275 reports)
Cardiac failure (147,157 reports)

All the drugs that are associated with Cardiac failure:

Cardiac failure (2,055 drugs)

All the conditions that are associated with Cardiac failure:

Cardiac failure (2,210 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cardiac failure and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.